Paracetamol (PCT) is a mostly used analgesic and antipyretic drug [1]. Overdoses can cause of liver and kidney damage [2]. The primary metabolism of PCT occurred in the liver and some of the metabolites show toxic interaction with the amino acid residue of receptor protein [3]. Paracetamol sulphate (PCT-S) is a primary metabolite, which is formed by sulphate conjugation of PCT and mainly found in children. Similarly, paracetamol glucuronide (PCT-G) is another primary metabolite, which is also formed by glucuronide conjugation of PCT and mainly found in adult. N-acetylp-benzoquinone imine (NAPQI) is one of the toxic metabolites, produced by cytochrome P450 (CYP450) mediated N-hydroxylation of . Till now, the metabolite formation and their action are not completely known. Previously, some of the metabolites were detected and reported by many researchers [3,8]. Attempt has taken to optimize the reported metabolites to make more understandable about the metabolite's formation, their inherent stability, chemical reactivity, binding affinity, and toxic parameters. The enthalpy, free energy, dipole moment, molecular orbital, chemical hardness, softness, electrostatic potentiality has been reported to compare the inherent stability, chemical reactivity. In addition, molecular docking has been performed against prostaglandin synthase protein (5F19) to compare their binding affinity, and mode(s).ADMET prediction has been performed to compare the absorption, metabolism, and safety level for oral administration of all optimized structures (Figure 1). Figure 1: Some major metabolites of paracetamol.